NASDAQ:LYRA

Lyra Therapeutics Stock Insider Trading

etoro logo Buy LYRA
*Your capital is at risk
$0.495
+0 (+0%)
At Close: Jun 03, 2026

Lyra Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 1.85. In total, the insiders bought 17.8M and sold 126.54K LYRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
1.85
Buy 17.8M shares
Sell 126.54K shares
79% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Jun 01, 2026

Analysis Breakdown:

  • Weakened by a contradictory positive Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 13, 2024
Buy
Stock Option
A-Award
Merrifield C Ann
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Merrifield C Ann
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Smith W Bradford
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Snyderman Nancy Lynn Md
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Tobin James R
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Poukalov Konstantin
Director
Director 30 000
Value: $9K
Jun 13, 2024
Buy
Stock Option
A-Award
Altman Michael Seth
Director
Director 30 000
Value: $9K
Mar 18, 2024
Buy
Common Stock
A-Award
Waksal Harlan
Executive Chair
Officer 275 000
Value: $0
Mar 18, 2024
Buy
Stock Option
A-Award
Palasis Maria
President & CEO
CEO / President 500 000
Value: $2.89M
Mar 18, 2024
Buy
Stock Option
A-Award
Palasis Maria
President & CEO
CEO / President 500 000
Value: $2.89M
Mar 18, 2024
Buy
Common Stock
A-Award
Waksal Harlan
Executive Chair
Officer 275 000
Value: $0
Jan 30, 2024
Buy
Stock Options
A-Award
Bishop John E
Chief Technology Officer
Officer 200 000
Value: $916.0K
Jan 30, 2024
Buy
Stock Options
A-Award
Nieman Richard
Chief Medical Officer
Officer 200 000
Value: $916.0K
Jan 30, 2024
Buy
Stock Options
A-Award
Cavalier Jason
Chief Financial Officer
C-Suite Officer 200 000
Value: $916.0K
Jan 30, 2024
Buy
Stock Options
A-Award
Cavalier Jason
Chief Financial Officer
C-Suite Officer 200 000
Value: $916.0K
Jan 30, 2024
Buy
Stock Options
A-Award
Nieman Richard
Chief Medical Officer
Officer 200 000
Value: $916.0K
Jan 30, 2024
Buy
Stock Options
A-Award
Bishop John E
Chief Technology Officer
Officer 200 000
Value: $916.0K
Nov 10, 2023
Buy
Common Stock
P-Purchase
Waksal Harlan
Executive Chair
Officer 25 000
Value: $74.1K
Nov 10, 2023
Buy
Common Stock
P-Purchase
Waksal Harlan
Executive Chair
Officer 25 000
Value: $74.1K
Jun 30, 2023
Buy
Stock Option
A-Award
Tobin James R
Director
Director 20 000
Value: $82.2K
Jun 30, 2023
Buy
Stock Option
A-Award
Smith W Bradford
Director
Director 20 000
Value: $82.2K
Jun 30, 2023
Buy
Stock Option
A-Award
Poukalov Konstantin
Director
Director 20 000
Value: $82.2K
Jun 30, 2023
Buy
Stock Option
A-Award
Altman Michael Seth
Director
Director 20 000
Value: $82.2K
Jun 30, 2023
Buy
Stock Option
A-Award
Merrifield C Ann
Director
Director 20 000
Value: $82.2K
Jun 30, 2023
Buy
Stock Option
A-Award
Anderson Edward T
Director 20 000
Value: $82.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LYRA THERAPEUTICS INC.
Lyra Therapeutics
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflam...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE